Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.

A prospective multicenter study of cryptococcal immune reconstitution inflammatory syndrome (IRIS) was conducted as a substudy of the Bacteriology and Mycology Study Group 3-01. Of 101 AIDS patients with cryptococcal meningitis who received highly active antiretroviral therapy (HAART), 13 experienced cryptococcal IRIS. No association between the timing of HAART initiation and the diagnosis of IRIS was identified. Increased baseline serum cryptococcal antigen (CrAg) titer was a risk factor for cryptococcal IRIS.

[1]  J. Sobel,et al.  A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  D. Boulware,et al.  Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  S. Kiertiburanakul,et al.  Timing of cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in patients with AIDS and cryptococcal meningitis. , 2007, Journal of acquired immune deficiency syndromes.

[4]  S. Kiertiburanakul,et al.  Impact of antiretroviral therapy on the relapse of cryptococcosis and survival of HIV-infected patients with cryptococcal infection. , 2007, Current HIV research.

[5]  F. Dromer,et al.  Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France , 2005, AIDS.

[6]  S. Shelburne,et al.  The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  P. Price,et al.  Immune restoration disease after antiretroviral therapy , 2004, AIDS.

[8]  M. Battegay,et al.  Immune reconstitution in HIV-infected patients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  A. Vibhagool,et al.  Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis , 2003, AIDS.

[10]  E. Jenny-Avital,et al.  Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  W. Chan,et al.  Immunorestitution disease involving the innate and adaptive response. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  M. John,et al.  Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy , 2000, HIV medicine.

[13]  N. Letvin,et al.  Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease , 1998, The Lancet.